2013

December 2013 

•  Is it necessary to understand the MoA?
• Christopher A Bravery, PhD
• Speaker, chair intro
• Informa’s 4th Annual Cell Therapy Manufacturing
• Brussels, Belgium.

October 2013

• Potency Assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry
• Dr. Christopher Bravery, PhD
• Speaker, moderator
• IBC’s 3^rd Annual Cell Therapy Bioprocessing Conference
• Bethesda, USA.

June 2013

• Understanding Mechanisms of Action and Identifying Relevant Biological Activities: Why are they so important? 
• Dr. Christopher Bravery, PhD
• Speaker
• PDA Europe, Advanced Therapy Medicinal Products Conference
• Florence, Italy.

• Navigating the Uncertainties of Product Quality
• Dr. Christopher Bravery, PhD
• Speaker
• IChemE, Biomedical Engineering Special Interest Group: Product Development in Regenerative Medicine.
• London UK.

April 2013

• "19th Annual ISCT Meeting"
• Dr. Christopher Bravery, PhD
• Preconference GRP chair, session chair.
• Skycity Auckland Convention Center
• Auckland, New Zealand

 

January 2013

• Workshop moderator and "Potency ISCT-PPD" 
• Dr. Christopher Bravery, PhD
• Workshop, speaker
• "Phacilitate. Cell & Gene therapy forum 2013".
• Grand Hyatt, Washington, DC.